Open AccessComparative clinical trial of S-pantoprazoleversusracemic pantoprazole in the treatment of gastro-esophageal reflux disease
Author(s) -
Vikas Pai,
Nitin Pai,
Hemant Thacker,
Jyotsna S. Shinde,
Vijay P Mandora,
S. S. Erram
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i37.6017
Subject(s) - pantoprazole , heartburn , medicine , gastroenterology , gerd , bloating , tolerability , esophagogastroduodenoscopy , reflux , nausea , adverse effect , dysphagia , omeprazole , surgery , endoscopy , disease
To compare the efficacy and tolerability of S-pantoprazole (20 mg once a day) versus racemic pantoprazole (40 mg once a day) in the treatment of gastro-esophageal reflux disease (GERD).